Is Repurposing Drugs the Way to Beat Covid? Maybe. Maybe not. An Expert Weighs In.

Links to Files

https://www.acsh.org/news/2020/08/13/repurposing-drugs-way-beat-covid-maybe-maybe-not-expert-weighs-14968

Permanent Link

http://hdl.handle.net/11603/39622

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department

Author/Creator

Author/Creator ORCID

https://orcid.org/0000-0002-0154-3459

Date

2020-08-13

Type of Work

articles
Text

Department

Program

Citation of Original Publication

Seley-Radtke, Katherine, and Josh Bloom. “Is Repurposing Drugs the Way to Beat Covid? Maybe. Maybe Not. An Expert Weighs In.” American Council on Science and Health. August 13, 2020. https://www.acsh.org/news/2020/08/13/repurposing-drugs-way-beat-covid-maybe-maybe-not-expert-weighs-14968.

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Subjects

antiviral drug
SARS-CoV-2
COVID-19

Abstract

There are both advantages and disadvantages of studying repurposed drugs to battle COVID-19. In an interview, ACSH advisor Dr. Kathie Seley-Radtke weighs in on this method while providing a glimpse at some of the very promising research now going on in her lab. If you want to know how antiviral drug discovery might tame COVID-19, this is a must-read.